Cancer-Related Fatigue
Cancer-related fatigue, experienced by nearly all cancer patients, is a form of acute or chronic emotional, mental, and physical fatigue resulting from cancer and its treatments, such as chemotherapy, immunotherapy, or bone marrow transplantation. This debilitating condition can significantly impact the quality of life for those undergoing cancer therapy.
Health Outcomes
- Accelerated Recovery in Immunocompromised Mice
- Beneficial Clinical Effects
- Cancer-Related Supportive Effects
- Enhanced Survival Under Stress
- Enhanced Tolerance Acquisition
- Improved Anti-Oxidative Effects
- Improved Average Power
- Improved Cancer Treatment Tolerance
- Improved Cancer-Related Health Outcome
- Improved Catalase Level
- Improved Countermovement Jump Power
- Improved Endurance
- Improved Exercise Recovery
- Improved Exertion and Emotional Perceptions
- Improved Fatigue
- Improved Fatigue Index
- Improved Fatigue Parameter
- Improved Fatigue Ratio
- Improved Fatigue Symptoms
- Improved Fatigue Threshold
- Improved Fatigue Tolerance
- Improved Fatigue-Associated Features
- Improved General Activity
- Improved Global Quality of Life
- Improved Global Symptom
- Improved Health Condition
- Improved Health Perception
- Improved Immune Surveillance
- Improved Karnofsky Performance Status
- Improved Medicine-Ball Throw
- Improved Perceived Exertion
- Improved Performance Decrement Index
- Improved Performance Status
- Improved Physical Domain Score
- Improved Physical Work Capacity
- Improved Quality of Life
- Improved Recovery in Immunocompromised Individuals
- Improved Sprint Repeat Task Performance
- Improved Time to Exhaustion
- Improved Time-Trial Performance
- Improved Tiredness Symptom Score
- Improved Various Elements
- Improved Vigor
- Improved Vigor-Activity
- Improved Vitality
- Improved Willingness to Continue Treatment
- Improved Work Above End Power
- Improved Yo-Yo Test Performance
- Increased Angiogenesis
- Increased Fatigue Threshold During Exercise
- Increased Occurrence of Serious Adverse Events
- Increased Perceived Exertion
- Increased Production of Bioactive Metabolites
- Increased Satisfaction
- Increased Total Thiol Level
- Increased Vitality
- Inhibited Activation of Apoptotic Biomarkers
- Maintained Cell Viability in Low pH
- Maintenance of NK Cell Activity
- No Significant Effect on Diarrhea
- Persistent Fatigue
- Reduced Adipose Tissue Wasting
- Reduced Adverse Event
- Reduced Adverse Event from Radiotherapy or Chemotherapy
- Reduced Apoptosis
- Reduced Appetite Loss Incidence
- Reduced Behavioral Fatigue
- Reduced Cancer-Related Fatigue
- Reduced Cellular Damage
- Reduced Composite Symptom Score
- Reduced Disease Symptoms
- Reduced Disease-Related Fatigue
- Reduced Energy Intake
- Reduced Exhaustion
- Reduced Fatigue
- Reduced Fatigue Decrement
- Reduced Fatigue Index
- Reduced Fatigue Levels
- Reduced Fatigue Severity
- Reduced Fatigue-Inertia
- Reduced Functional Iron Deficiency
- Reduced Immune Cell Infiltration
- Reduced Incidence of Adverse Reaction
- Reduced Lethargy
- Reduced Mental Fatigue
- Reduced Neuromuscular Fatigue
- Reduced Power
- Reduced Psychological Fatigue
- Reduced Rating of Perceived Exertion
- Reduced Risk of COVID-19 Progression
- Reduced Subjective Symptoms
- Reduced T Cell Responsiveness
- Reduced Tiredness
- Supportive Effect in Breast Cancer Management